The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
CDF1 -
I'm not going to post the questions from the TG group as would need to seek approval from too many others.
Investors can join the group, just DM one of the admins. I have found it very helpful.
There were only a few questions regarding Dunrobin, I just found it interesting that it wasn't mentioned at all.
Sorry I can't be of more help.
Approximately 2 weeks ago, 20 questions were compiled in the TG group and sent to the BoD.
Their reply was in the form of an interview.
There were questions regarding Dunrobin.
No mention of Dunrobin in the interview.
Either nothing to say, could be under NDA, or something else.
Gla
Not listing on aim, was there before aquis listing.
Listing is on to main market.
The placing was oversubscribed.
Hoping list price will be 10p.
Then see what the market thinks Monday morning!
I'm very pleased CTW is considering extending the 12p warrants for another 2 years. That would show great confidence in the company and is a nice gesture to those that were onboard early.
https://polaris.brighterir.com/public/altona/news/rns/story/x8eop5x
Upcoming zoom meeting to discuss 12p warrants.
https://twitter.com/StockBoxMedia/status/1635598366347259904
http://www.alignresearch.co.uk/cpt-company/altona-rare-earths/
No specified date yet. See Stockbox interview:
https://t.co/anyTRjNFsL
Well it seems Altona will be listing on the main market finally.
I look forward to it.
I don't think any warrants will be exercised.
Why buy at 2.5p when you could, just a couple of months before they expire, buy at a quarter of the price.
This is why a large funding package is absolutely necessary.